Stay updated on Itolizumab in Uncontrolled Asthma Clinical Trial
Sign up to get notified when there's something new on the Itolizumab in Uncontrolled Asthma Clinical Trial page.

Latest updates to the Itolizumab in Uncontrolled Asthma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study page revision label was updated from v3.6.2 to v3.6.3, indicating a new version of the page in the revision history.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page revision has been updated from v3.6.0 to v3.6.2, indicating a newer build of the study page. This is likely a routine maintenance or minor update rather than changes to the trial details.SummaryDifference0.0%

- Check39 days agoChange DetectedRecruitment status now shows that the study is not accepting participants, and new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') were added. Additionally, the 'Intervention/Treatment' header formatting was standardized by removing the extra space around the slash, and the revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check47 days agoChange DetectedA new revision tag (v3.5.5) and recent update dates (May and June 2026) were added to the study record, indicating ongoing maintenance of the entry. The collaborator listing was updated by removing Equillium AUS Pty Ltd.SummaryDifference0.6%

- Check68 days agoChange DetectedThe revision tag on the page updated from v3.5.3 to v3.5.4. This appears to be a backend or documentation update rather than a change to the study data presented.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page updates its display revision from v3.5.2 to v3.5.3, reflecting a site software/version change with no evident impact on the study’s recorded content.SummaryDifference0.1%

Stay in the know with updates to Itolizumab in Uncontrolled Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Itolizumab in Uncontrolled Asthma Clinical Trial page.